Impaired inhibition of P2Y12 by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention-Reference-Cited by-同舟云学术

Impaired inhibition of P2Y12 by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention

Published:2011-08 Issue:2 Volume:217 Page:465-472
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

El Ghannudi S.,Ohlmann P.,Jesel L.,Radulescu B.,El Adraa E.,Crimizade U.,Wiesel M.L.,Gachet C.,Morel O.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. New aspects in the pathogenesis of diabetic atherothrombosis;Moreno;J Am Coll Cardiol,2004

2. Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease;Muller;Atherosclerosis,2010

3. Diabetes and the platelet: toward new paradigm in diabetic atherothrombosis;Morel;Atherosclerosis,2010

4. Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions;Angiolillo;Diabetes Care,2009

5. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease;Angiolillo;J Am Coll Cardiol,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats;Biochemical Pharmacology;2020-10

2. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention;Cardiovascular Diabetology;2019-11-09

3. In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention;Medicine;2019-02

4. Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors;Journal of Atherosclerosis and Thrombosis;2018-08-01

5. Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants;Stroke;2017-04